August 05, 2020
A Minnesota federal judge denied class certification to EpiPen buyers Wednesday in a suit accusing Express Scripts, CVS Health and other pharmacy benefit managers of violating the Employee Retirement Income Security Act by causing plan participants to overpay for the device.
December 17, 2019
A proposed class of EpiPen buyers is asking a Minnesota federal judge for certification in their suit accusing Express Scripts, CVS Health and other pharmacy benefit managers of violating ERISA by causing plan participants to overpay for the drug.
October 26, 2018
A Minnesota federal judge on Friday refused to completely toss an Employee Retirement Income Security Act suit accusing Express Scripts Holding Co., CVS Health Corp. and other pharmacy benefit managers of causing large increases to EpiPen's list price, but did find that some claims failed.
June 04, 2018
Express Scripts Holding Co., CVS Health Corp. and other pharmacy benefit managers urged a Minnesota federal judge Friday to toss a proposed class action alleging that they breached their Employee Retirement Income Security Act duties and caused large increases to EpiPen's list price, arguing that the companies weren't fiduciaries subject to the law.
June 05, 2017
Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers of violating the Employee Retirement Income Security Act by putting their own interests before those of patients.